Skip to main navigation Skip to search Skip to main content

SBIR: NIH Phase II-UNCD as Bio-Inert Interface for Anti-Thrombogenicity Applications in

Project: Research

Project Details

StatusFinished
Effective start/end date09/18/13 → 01/31/16

Funding

  • National Heart Lung and Blood Institute: $109,220.00